🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
0.2253
+0.0115 (5.38%)
At close: Nov 20, 2026, 4:00 PM EST
0.2004
-0.0249 (-11.05%)
After-hours: Nov 20, 2026, 7:56 PM EST

Actuate Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
12142155--
Market Cap Growth
-90.89%-8.51%---
Enterprise Value
10125142--
Last Close Price
0.236.127.96--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
PB Ratio
-17.951492.25--
P/TBV Ratio
-17.951492.25--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Debt / Equity Ratio
2.60-1.66-82.940.66-1.31
Quick Ratio
0.582.310.980.434.71
Current Ratio
0.732.391.050.434.71
Return on Equity (ROE)
-364.70%-553.75%--442.40%-
Return on Assets (ROA)
-176.44%-190.35%-443.16%-210.78%-98.42%
Return on Capital Employed (ROCE)
4638.90%-270.10%-4876.60%636.30%-125.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-344.52%-15.63%-17.55%--
Buyback Yield / Dilution
-18.80%-151.07%-483.48%-18.54%-
SEC Filings: 10-K · 10-Q